Published in Gene Therapy Weekly, March 14th, 2002
A multicenter investigation conducted in London, England has yielded information suggesting mice that are apolipoprotein E (apoE) deficient (apoE-/-) improve in terms of atherosclerotic progression after their skeletal muscles are made to generate low levels of the protein. Because atherosclerotic changes in the mice mirror those of humans, authors of the new study believe similar therapy could help people with vascular disease.
J. Harris and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.